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Impact of the Maternity Care Changes of the COVID-19 Pandemic on Pregnant Women
and Their Birth Partners: An Integrative Literature Review
The emergence of the COVID-19 virus has had a dramatic effect on the lives of everyone
worldwide. Originally identified as a pneumonia of unknown cause, COVID-19 was first
reported to the World Health Organization (WHO) Country Office in China on New Year’s Eve
2019 (Hocaoglu et al., 2020). This virus, that has since come to be known as a pandemic,
emerged on the global scene in late 2019 and early 2020 out of the Wuhan province of China and
is part of the family of coronaviruses. Coronaviruses are RNA viruses enveloped with the
genome consisting of a single stranded positive sense RNA, and are divided into four sections,
A-D (Rahaman, 2020). B coronaviruses contain the extreme acute respiratory syndrome (SARS)
and the novel SARS-CoV-2 (“COVID-19”). C coronaviruses are linked to Middle Eastern
Respiratory Syndrome (MERS). SARS-CoV-2, or COVID-19, is the newest and most virulent
member of the coronavirus family. Uncertainty exists surrounding the exact origin of the SARSCoV-2 virus. In the scientific community there is discussion that SARS-CoV-2 originated in
horseshoe bats with pangolins proposed to be the intermediate host between animals and humans
(Lam et al., 2020; Rahaman, 2020; Wrobel et al., 2021; Xiao et al., 2020; Zhang et al., 2021).
Roberts et al. (2021) address the uncertainty surrounding the origin of COVID-19 through the
application of the Optimal Linear Estimation (OLE) method originally proposed by Roberts and
Solow (2003) for dating extinctions. By applying OLE, Roberts et al. (2021) were able to
examine exceptionally early cases of SARS-CoV-2, calling into question the theory of zoonotic
overproduction from the Huanan Seafood Market in Wuhan, China. According to Roberts et al.
(2021), rationale for investigating the origin of SARS-CoV-2 is contained in the existence of
earlier potential cases of COVID-19 and phylogenetic analyses placing the most recent ancestor
occurring between mid-November and early December 2019. Roberts et al. (2021) discovered a
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COVID-19 case in France through a retrospective review of medical records. The identified
patient had presented to the emergency department on December 27, 2019, with influenza
symptoms and was then admitted to the intensive care unit (ICU). Further, Roberts et al. (2021)
discovered that in the United States, SARS-CoV-2 RNA was detected through retrospective RTPCR testing of a woman who had become ill on January 31, 2020 and died on February 6, 2020.
This case occurred over three weeks before the first recognized American case on February 26,
2020. Andersen et al. (2020), Nsoesie et al. (2020), and Zhang and Holmes (2020) support
Roberts et al. (2021) in the purporting of early cases of COVID-19 in the fall of 2019. Authors
claim manipulation of the SARS-CoV-2 virus in the intermediary stages between species would
allow it to originally go undetected and explanation the early cases.
The family of B coronaviruses is known for causing illnesses that range from the
common cold to severe respiratory disease and death (Rahaman, 2020). Transmission occurs
primarily through contact between a person and the virus host. More specifically, transmission
occurs through the infected person’s respiratory droplets which are deposited into the air and
then onto nearby surfaces. According to the Centers for Disease Control and Prevention (CDC),
there are three specific categories of transmission, which are inhalation of the virus, deposition of
the virus on exposed mucous membranes, and touching mucous membranes with soiled hands
contaminated with virus (CDC, 2021). Respiratory droplets are capable of infecting people
within a distance of six feet and the ability of the virus to survive on nonliving surfaces makes
regular cleaning of touched surfaces important. Symptoms include fever, cough, myalgia,
vomiting, and diarrhea with an onset of approximately 14 days post exposure. Extent and
severity of an individual infection is primarily dependent upon that individual’s underlying
health. Patients with pre-existing conditions like diabetes, lung disease, and the elderly are
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among those who are most vulnerable to severe infection. Another group vulnerable to COVID19 are pregnant women. From a physical health perspective, the physiological changes of edema
and increased pulmonary expansion that occur in the respiratory tract during pregnancy make
pregnant women more susceptible to viral respiratory infections, including COVID-19 (de
Oliveira et al., 2021). Therefore, when a pregnant woman is diagnosed with COVID-19
increased inflammatory processes are observed leading to an exacerbation of the illness.
Additionally, the increased blood flow that occurs in pregnancy for the transportation of nutrients
to the fetus results in more severe and intense infections among pregnant women.
As SARS-CoV-2 has continued to mutate, variants of the virus have emerged as causes
of concern due to their ability to cause infection to a susceptible host (Cheng, 2022). The WHO
have classified the four SARS-CoV-2 variants of Alpha, Beta, Gamma, and Delta as variants of
concern (VOC). Alpha and Beta were both officially classified as VOC in December 2020 with
Alpha first detected in the United Kingdom in September 2020 and Beta first detected in South
Africa in May 2020. Gamma was first detected in Brazil in November 2020 and officially
classified as a VOC in January 2021. Delta was first detected in India in October 2020 and was
classified as a VOC in May 2021 due to its rapid global spread. The most recent VOC, Omicron,
was first detected in South Africa in November 2021 when it was also classified as a VOC
(Waltz, 2022). Omicron boasts dozens of mutations in its genetic code, approximately four times
as many as previous variants and differs drastically, both physically and genetically from other
variants.
Clinical Problem
In response to the COVID-19 pandemic, multiple vaccines have been developed by
various pharmaceutical companies. BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna)
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were the first COVID-19 vaccines available in the United States and were granted emergency
use authorization (EUA) by the Food and Drug Administration (FDA) in December 2020
(Shimabukuro et al., 2021). Administered as a two-dose series, 3 weeks apart for Pfizer–
BioNTech and 1 month apart for Moderna, the BNT162b2 and mRNA-1273 vaccines were
recommended for use by the Advisory Committee on Immunization Practices (ACIP) but
excluded pregnant women in the preauthorization clinical trials and provided limited human data
regarding safety during pregnancy at the time of authorization. Since pregnant women with
COVID-19 are at increased risk for severe illness, ICU admission, mechanical ventilation and
death when compared with non-pregnant persons (Acker et. al., 2021), as well as adverse
pregnancy outcomes, such as preterm birth, the CDC, ACIP, the American College of
Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics have
established that COVID-19 vaccines need not be postponed during pregnancy (Shimabukuro et
al., 2021). Specifically, the CDC recommends that women who are either pregnant,
breastfeeding, or plan on becoming pregnant receive a Pfizer or Moderna COVID-19 vaccine,
yet counsel patients to consult with their healthcare provider in making a final determination to
receive the vaccine (CDC, 2021). Centers for Disease Control and Prevention claim that none of
the COVID-19 vaccines contain live virus, and that evidence in favor of the safety and
effectiveness of the vaccine for pregnant women is growing, suggesting that the benefits
outweigh the potential risks (CDC, 2021). Similarly, ACOG recommends all eligible individuals
over the age of 12, including pregnant and lactating women receive a COVID-19 vaccine or
vaccine series (ACOG, 2021). As a result of the increased risk of adverse pregnancy and birth
outcomes for those diagnosed with COVID-19 while pregnant, and a greater severity of illness
compared to non-pregnant persons many countries have begun to vaccinate pregnant women,
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especially if they are at risk of being exposed (Ciapponi et al., 2021). In their rapid review,
Ciapponi et al. (2021) reported finding no evidence of safety concerns regarding the COVID-19
vaccines that the COVAX MIWG selected for review in August 2020, their components, or
platforms used in other vaccines during pregnancy. In a study consisting of 3958 participants
who identified as pregnant and were enrolled in the v-safe registry, 827 had a completed
pregnancy, out of which 115 (13.9%) were pregnancy losses and 712 (86.1%) were live births.
No neonatal deaths were reported, and adverse neonatal outcomes included pre-term birth (9.4%)
and small for gestational age (3.2%) (Shimabukuro et al., 2021). Prabhu et al. (2021) revealed
transplacental immunity in a study conducted at a single academic center. Out of 122 participants
all except for one showed detectable IgG antibodies in cord blood samples by week four after
receiving one dose of the COVID-19 vaccine. The lone couplet that was negative for antibody
transfer was 10 weeks post vaccine dose one and six weeks post dose two (Prabhu et al., 2021).
Rottenstreich et al. (2021) reinforce Prabhu et al. (2021) in support of transplacental
immunity to SARS-CoV-2 following maternal vaccination. In a study of 20 couplets conducted
at the Hadassah-Hebrew University Medical Center in Jerusalem, both mothers and infants were
positive for anti-spike protein (S) - and anti-receptor binding domain (RBD) - specific IgG.
Further, anti-S and anti-RBD-specific IgG levels in maternal blood were positively correlated to
their respective concentrations in cord blood. These results led to the conclusion that COVID-19
vaccines administered antenatally produced sufficient maternal immune response and
transplacental immunity transfer (Rottenstreich et al., 2021).
Kachikis et al. (2021) conducted a large prospective cohort study comparing
vaccine reactions and perceptions in pregnant and lactating individuals to individuals of similar
age and fertility intentions who were neither pregnant nor lactating and discovered that the
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vaccines were well tolerated among women who were pregnant, lactating, or planning
pregnancy. Day one reactions were reported to be similar among both groups and coincided with
previously reported findings. However, both groups reported increased reactions after receiving
the second dose of BNT162b2 and mRNA-1273 vaccines (Kachikis et al., 2021). Wainstock et
al. (2021) retrospective cohort study on the association between prenatal Pfizer-BioNTech
COVID-19 vaccination, pregnancy course and outcomes determined that prenatal maternal
COVID-19 vaccine has no adverse effects on pregnancy course and outcomes. Findings
indicated that the two dose vaccination series was associated with longer gestation and increased
birthweight compared to single dose, however, this may be due to the fact that women may have
delivered prior to receiving the second dose (Wainstock et al., 2021).
Background
Consequently, the COVID-19 pandemic necessitated lifestyle changes and brought about
new societal protocols such as mandatory wearing of masks in public and social distancing.
Rationale for these measures stems from the fact that reducing the risk of infection from
respiratory droplets can be achieved through distance from the infectious source as well as
containment of respiratory secretions and guarding mucous membranes (Acker et al., 2021).
Further, the risk of infection through aerosol transmission can be reduced through the wearing of
personal protective equipment (PPE) and remodeling ventilation. Hand hygiene serves as the
primary method of prevention by indirect contact. Internationally, healthcare systems have
implemented fundamental changes to their protocols and method of operations. Hospitals and
clinics reorganized patient appointments to decrease the number of patients in waiting rooms,
began placing visual reminders for patients to not sit side by side in a waiting room, reduced the
amount of furniture in their waiting rooms, and limited group activities (Acker et al., 2021).
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From a triage perspective, patients are screened upon arrival and prior to their appointment at a
healthcare facility. Globally, the World Health Organization (WHO) reports that there have been
628,346,704 confirmed cases of COVID-19 with 6,573,968 resulting in death. In the United
States, according to the Center for Disease Control (CDC), there have been 97,604,763 total
cases of COVID-19 with 1,068,667 resulting in death. Narrowed down to the state of Georgia,
the Georgia Department of Public Health (DPH) has reported a total of 2,252,117 total cases,
33,802 confirmed deaths, 128,742 hospitalizations, 17,087 ICU admissions, 672,615 antigen
positive cases, and 6,894 probable deaths.
One of the major concerns that has arisen out of this pandemic is its effect on the mental
health of millions of people worldwide (Perzow et al., 2021). Of specific concern is the mental
health of segments of the population considered to be at a higher risk or more vulnerable to
changes in mental health status. For pregnant women, considered to be a vulnerable population,
mental health effects can be compounded (Harrison et al, 2021). Pregnancy is a stressful period
due to its unique physiological and psychological changes. Koyucu and Karaca (2021) found that
pregnant women are at an increased risk for experiencing mental health issues such as anxiety
and depression and present three reasons why pregnant women might be stressed during the
COVID-19 pandemic:
1. Fear of contracting the infection
2. Fear of passing on the infection to their baby
3. Potential side effects on the fetus of antiseptics commonly used during the pandemic
Salehi et al. (2020) suggest that COVID-19 be considered as an influential factor in the mental
health of pregnant women due to the observed increase in anxiety amongst pregnant women for
their baby as well as their own health. Sharifi-Heris et al. (2021) note that pregnant women are in
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the high-risk category for traumatic mental health effects during a pandemic since both the
physiological as well as psychological changes combined with the motherhood transition led to
an increase in stress and anxiety.
Concerningly, the increase in prenatal anxiety, depression, and stress might result in poor
birth outcomes including miscarriage, preterm birth, low birth weight, and fetal death (Hocaoglu
et al., 2020). Koyucu and Karaca (2021) report that the frequency of obstetric complications
during labor and delivery in women diagnosed with mental illness is higher than that in the
general population while external stressors place them at risk for prenatal and postnatal
complications such as preeclampsia and gestational diabetes (Sharifi-Heris et al., 2021).
In addition to coping with the mental health challenges of pregnancy during a pandemic,
pregnant women and their birth partners have experienced logistical modifications to maternity
care brought about to combat the COVID-19 virus. Osborne et al., 2021 mention that labor and
delivery is one of the few medical procedures that cannot be delayed. With hospitals having to
revise protocols and procedures, fathers, doulas, and other birth support persons were restricted
from accompanying the laboring women through the birthing process. Also included in the
hospital restriction guidelines was the temporary separation of infected women from their
newborn. However, due to emerging CDC evidence revealing a low rate of viral transmission
between infected mother and newborn, the WHO and the American Academy of Pediatrics
revised the restrictions and recommend placing the newborn in the room with the mother. To
prevent the transmission of the virus between the mother and newborn, the WHO and American
Academy of Pediatrics have suggested an infected mother practice hand hygiene and utilize a
face mask. Length of hospital stay post-partum is an additional adjustment healthcare facilities
made during the early stages of the COVID-19 pandemic. Pariente et al. (2020) mention that at
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the onset of the pandemic, healthy mothers and newborns experienced a shorter hospital stay in
an effort to avoid contamination with SARS-CoV-2. Mothers were also staying in their assigned
hospital room rather than ambulating around the unit which limited their opportunity to become
mobile post-partum. Once discharged from the hospital, Boekhorst et al. (2021), GonzalezGarcia et al. (2021), and Perzow (2021) all report that the social isolation induced by the
lockdown led to a decline in outside family support for the post-partum mother. Resultingly, the
lack of post-partum social support revealed a negative impact on the mental health of the mother,
including increased depression, stress, and anxiety. Difficulty in prevention of disease
transmission while in the hospital has also been presented. Breslin et al. (2020) and Liu et al.
(2020) report finding pregnant women presenting to the hospital for delivery and testing positive
for COVID-19 despite being asymptomatic. The Breslin et al. (2020) study occurred in New
York City and discovered that many of the pregnant women who tested positive for COVID-19
in the city were asymptomatic. Liu et al. (2020) detailed results of a study of 15 cases of
pregnant women with COVID-19 two of whom were asymptomatic. Recommendations were
therefore given to conduct universal testing of all pregnant women presenting to the labor and
delivery unit of a hospital.
Regarding antenatal care, Muhaidat et al. (2020) discovered a decline in pregnant women
receiving healthcare during their pregnancy. Results from the Muhaidat et al. (2020) study
revealed that only 4% of participants lacked antenatal care prior to the lockdown period of the
pandemic, but as much as 59.5% lacked antenatal care during the lockdown. Karavadra et al.
(2020) report that antenatal care transitioned to the virtual platform during the lockdown period.
Moyer et al. (2020) echo Karavadra et al. (2020) through a study that revealed 25.8% of women
ceased in-person antenatal care after the onset of the COVID-19 pandemic. In the same study,
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Moyer et al. (2020) inform that 15.2% of participants utilized a video visit for prenatal care and
31.8% utilized a phone visit. When in-person antenatal care was provided, restrictions dictated
that the pregnant woman attend the appointment alone (Cullen et al., 2021). Because the
pregnant woman was alone, birth partners unfortunately missed pivotal routine antenatal
appointments such as ultrasounds, gender reveals, and hearing the baby’s heartbeat.
Because of the changes and modifications to maternity care, Acker et al. (2021)
recommends beginning patient education regarding transmission and signs and symptoms of
COVID-19 at the inaugural antepartum visit and continue educating throughout pregnancy and
postpartum. Included in the patient education is the instruction for the patient to notify the
provider of the development of respiratory symptoms or exposure. Identified by Karavadra et al.
(2020) as a commonality among study participants, birthing partners not being allowed during
labor induced a sense of worry for pregnant women. Shayganfard et al. (2020) discovered that
increased health anxiety resulted in pregnant women postponing or canceling their routine health
care appointments, thereby establishing a connection between mental health and health behavior
changes. Currently, pregnant women are encouraged to identify a primary support person to stay
with them during their hospital admission and to also have an alternate support person available
in the event that the primary support person screen or test positive for COVID-19 or become
exposed to the virus (Acker et al., 2021). Upon admission to the antepartum unit, patients are
screened and tested for SARS-CoV-2 with repeat screening occurring in the labor and delivery
unit and post-partum unit. As stated earlier, COVID-19 positive patients are encouraged to wear
a surgical mask while in the presence of others, including their newborn, throughout their
hospitalization, and to perform hand hygiene prior to contact with their infant.
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Due to the impact the COVID-19 pandemic has had on pregnant women, a literature
review focused on how the COVID-19 pandemic has affected the mental health of the pregnant
population and resulting health behavior changes was determined to be valuable. The primary
rationale for conducting this integrative review is the fact that preliminary research has revealed
that the COVID-19 pandemic has yielded an increase in psychological distress among expectant
mothers (Cameron et al., 2020). In a mixed-methods study, Farewell et al. (2020) reported that
the prevalence of prenatal and postpartum depression is estimated at 12% and 17%, respectively.
Exposure to environmental factors, such as natural disasters, have the potential to amplify
perinatal mood disorders that can result in intergenerational impacts on child health and
development outcomes. A second rationale for research and study of this topic is the gap in
literature regarding the mental health implications related to perinatal mental health during
COVID-19 (Koyucu & Karaca, 2021; Overbeck et al., 2021; Sharifi-Heris et al., 2021).
Gonzalez-Garcia et al. (2021) have similar support of research and study on the impact of
COVID-19 on the mental health of pregnant women by reporting that in “normal” times 1 in 5
women develops an anxiety disorder during the perinatal period, and that meta-analysis has
indicated that the prevalence of postpartum PTSD is 3.1%. This highlights that the containment
and other health measures of the pandemic have compounded the tiring, trying, and painful stage
of life that pregnancy, labor, and childbirth is with women having to deal with restricted social
dialog, greater isolation, and less family support. Arising out of the reports from the literature,
the discovered gap in the literature, and the novelty of the SARS-CoV-2 virus, a literature review
on the impact of the COVID-19 pandemic on the mental health of pregnant women and resulting
health behavior changes was undertaken.
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Method
This integrative review was conducted through a search of the literature on the Kennesaw
State University library website, CINAHL database and the reference lists of articles obtained
through these two sources. The literature search was conducted intermittently from January 2021
until April 2022. Aforementioned databases were searched for published, peer-reviewed research
studies that were either qualitative or quantitative. Given the recent emergence of the topic, the
time frame was self-limited to articles published from April 2020 through April 2022. Keywords
searched included “COVID-19”, “pregnancy”, and “pregnant women”. MeSH search terms
included “COVID-19 and pregnancy” and “COVID-19 and pregnant women”. Criteria for
inclusion were articles located that were relevant to the topic of the literature review, qualitative,
quantitative, or mixed-methods studies, and published in a scientific, medical, or nursing journal
from April 2020 – April 2022. Criteria for exclusion were articles located that did not
specifically address the impact of COVID-19 on the mental health of pregnant women and their
health behaviors or were strictly opinion pieces regarding the impact of COVID-19 on the mental
health of pregnant women and their health behaviors. Additional exclusion criteria were articles
that addressed the mental health of pregnant women and their health behaviors but did not
include both pre and post COVID-19 data. A PRISMA flow diagram detailing the literature
search is included as Appendix A.
Data Analysis
An integrative review is conducted through examining evidence for the purpose of
revealing complex concepts related to health care problems of importance to the nursing
profession (Whittemore & Knafl, 2005). Further, an integrative review provides a holistic
understanding of the subject matter and enhances evidence based practice initiatives. However,
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there must be specific and systematic methods utilized during the integrative review process to
reduce the risk of error. Therefore, strategies recommended by Whittemore and Knafl (2005)
were utilized as the foundation for the completion of this integrative review. Specifically
employed were the five stages of review, known as problem identification, literature search,
data evaluation, data analysis, and presentation. Elements of data analysis from Whittemore and
Knafl (2005) were consulted to inform how best to analyze and present data. Particular elements
of data analysis employed during this integrative review were noting patterns and themes,
clustering, making contrasts and comparisons, discerning common and unusual patterns,
subsuming particulars into general, and finding intervening factors. Applying this approach,
details of the eight studies selected for data analysis are discussed.
Gonazlez-Garcia et al. (2021) conducted a study analyzing the concept of the anxiety
associated with the COVID-19 pandemic potentially compounding mood disorders that are
routinely experienced by new and expecting mothers. In consideration of the effects that the
COVID-19 pandemic could have on the affect of pregnant and postpartum women, the authors
studied both the coping strategies and protective factors of the mothers. Quarantine along with
the other health measures enforced by the COVID-19 pandemic, particularly social limitations,
increased isolation, and decreased family support are suggestions for the escalation in mood
disorders seen in this population. Five hypotheses were examined:
1. Low level of social support during the pandemic would be associated with increased
concerns for the baby during pregnancy.
2. Greater degree of concern about the baby during quarantine would be associated with
higher antenatal levels of anxiety and depression symptoms.
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3. The prevalence of anxiety and traumatic symptoms would be higher during the
quarantine period than outside the quarantine period.
4. Quarantine measures would impact emotional soothing as a regulatory strategy.
5. The crisis would challenge points of view and trigger posttraumatic growth, which would
prompt a positive reevaluation of situations and influence emotional regulation strategies.
This study was comprised of 90 pregnant women who were in their second or third trimester
during France’s first lockdown period (April 06 – May 11, 2020). All of the participants
completed questionnaires during pregnancy (T1), but only 26 (40.6%) completed the
questionnaires one month postpartum (T2). Questionnaires completed by participants at T1
included the Spielberger Trait Anxiety Inventory (STAI), the Edinburgh Postnatal Depression
Scale (EPDS), and the Multidimensional Scale of Perceived Social Support (MSPSS).
Questionnaires completed at T2 included the City Birth Trauma Scale (CBTS), the Interpersonal
Emotional Regulation Questionnaire (IERQ), and the Posttraumatic Growth Inventory (PGI).
Results for hypothesis number one confirmed that the level of worry about the baby generated by
COVID-19 was significantly and negatively associated with the degree of perceived social
support. Results for hypothesis number two revealed a significant difference between depression
scores at T1 versus T2 with the scoring guide indicating possible depression in 9 participants.
These results validated the authors second hypothesis as there was a significant positive
correlation between the concern for the baby on one hand and the mother's symptoms of anxiety
and depression on the other. Results for hypothesis number three indicated that the prevalence of
postpartum PTSD amongst study participants was around 3% with one of the 26 participants
meeting criteria for PTSD at T2. Results for hypothesis three also revealed that the mean prenatal
anxiety symptom score during the COVID-19 pandemic appeared to be higher than in a control
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population in the literature prior to the pandemic (M=42.77, SD=12.06. Scale 20-80: (very high
>65), high (56−65), medium (46−55), low (36−45) or very low (<35)). Regarding hypothesis
number four, the authors unexpectedly discovered that soothing ability was not considerably
connected to worrying about COVID-19. Results for hypothesis number five revealed that
posttraumatic growth was not significantly correlated with any of the interpersonal emotion
regulation subscales. Results of this study indicate that the potential impact of COVID-19 needs
to be taken into consideration when assessing possible psychological disorders in perinatal
women.
Moyer et al. (2020) sought to explore the impact of the COVID-19 pandemic on pregnant
women’s anxiety and to identify factors that most strongly contribute to increased changes in
anxiety. The authors conducted a cross-sectional study whereby 2,740 participants from 47 states
completed a survey consisting of a modified pregnancy-related anxiety scale (PRAS) to reflect
perceptions of pregnancy anxiety prior to COVID-19 versus during COVID-19. Responses from
participants revealed that due to the pandemic 25.8% (N=706) ceased in-person visits, 15.2%
(N=415) utilized video visits, and 31.8% (N=817) utilized phone visits for prenatal care. Further,
the number of participants planning a hospital birth decreased from 2641 (96.4%) to 2400
(87.7%). Categories of stress reported by the participants included food supply (59.2% N=1622),
job or household income loss (63.7%, N=1745), loss of childcare (56.3%, N=1543), conflict
between household members (37.5% N=1028), and being infected with COVID-19 (93%,
N=2556). Of note is that 41.4% (N=1133) of participants or their family members were
healthcare workers and 45.5% (N=1246) were employed in essential services. Also of note is the
fact that 35.9% (N=982) of the participants had previously diagnosed depression, anxiety, or
other mental health issue. Through multivariate analysis, the authors were able to observe that
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participants who expressed a greater agreement with COVID-19 related stressors experienced
more significant changes from pre to post COVID-19 pregnancy related anxiety. Moyer et al.
(2020) agree with Gonzalez-Garcia et al. (2021) in expressing that the rapidly changing context
and high degree of uncertainty surrounding childbirth during the pandemic serves to increase the
anxiety amongst this population during a time when stress is already heightened. Anxiety was
measured multiple ways. First, the authors utilized a 10-point visual analog scale (VAS) to assess
anxiety about being pregnant during the COVID-19 pandemic. On this VAS, 1 indicated not
being anxious at all and 10 indicated being extremely anxious. The authors then utilized a second
VAS to assess anxiety about childbirth during the COVID-19 pandemic in addition to the
modified version of the PRAS. Instructions for the PRAS included recalling emotions prior to
the pandemic and then answering the same questions based on current emotions during the
pandemic. It was the difference between these two scores that the authors used as their outcome
variable. Factors that were significantly associated with greater changes in PRAS scores included
being in the 3rd trimester, history of or recent diagnosis of depression or anxiety, ceasing inperson prenatal care, and change of delivery location away from the hospital. Alternatively,
factors associated with smaller changes in PRAS scores included higher maternal age, higher
education, being married, and planning a home birth. Mean PRAS scores for perceptions preCOVID were 20.6% but were 23.9% during the pandemic. Anxiety scores revealed that the
participants were more anxious about childbirth during the pandemic (mean 7.6 on scale of 1-10)
then about being pregnant during the pandemic (mean 6.5 on scale of 1-10). Comparing the
anxiety scores against the study’s outcome measure led the authors to the conclusion that greater
anxiety regarding pregnancy and childbirth was significantly associated with greater changes in
PRAS scores. Given the fact that COVID-19 related issues (ex. becoming infected with the virus,
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ceasing in-person prenatal care, and delivering outside the hospital), food insecurity, and tension
in the home were the issues most strongly associated with greater changes in pregnancy related
anxiety, the authors concluded that the pandemic is having a weighty impact on pregnancy
related anxiety. Additionally, two important factors regarding pregnancy related anxiety have
been exhibited through this study and magnified by the COVID-19 pandemic:
1. Real or anticipated threat to pregnancy or its outcomes
2. Low perceived control
This was the first American study to examine both COVID-19 related anxiety together with
pregnancy-related anxiety and highlights to providers the importance of recognizing that
pregnant women’s anxiety surrounding COVID-19 is likely to carry over and be expressed as
pregnancy-related anxiety.
Overbeck et al. (2021) provided insight regarding the mental health of pregnant women
in Denmark during COVID-19 through assessing symptoms of anxiety and depression. This
assessment was completed by analyzing data from two cohorts of pregnant women. One group,
named the COVID-19 cohort (N=330) was recruited from April 08 – May 06, 2020, completed
questionnaires, and was compared to a control cohort from 2016 (N=1428). Both groups were
recruited by general practitioners in Capital Region and Region Zealand during their first
prenatal consultation. In both groups, mental health was assessed using the Major Depression
Inventory (MDI) and the Anxiety Symptoms Scale (ASS). There was no difference observed
between the two cohorts regarding depressive symptoms, however, anxiety symptoms were
observed to be slightly worse in the COVID-19 cohort (mean difference = 1.4 points) with the
greatest difference occurring during the first trimester (adjusted mean = 4 points). In contrast to
the Gonzalez-Garcia et al. (2021) and Moyer et al. (2020) studies, the Danish National Health
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Services regarded preventive antenatal services as high priority, and did not pause prenatal
services during lockdown, although some general practitioners and midwives reorganized some
of the appointments to be video consultations. Another contrast is that unlike with the Moyer et
al. (2020) study, none of the participants in this study had a previous diagnosis of anxiety or
depression. The authors noted higher levels of general anxiety and avoidance behavior but lower
social phobia amongst the COVID-19 cohort, and no significant difference for the other items.
Perzow et al. (2021) assessed the changes in anxiety and depression symptoms prior to
and during the COVID-19 pandemic among pregnant and post - partum women through a
longitudinal study. Participant population was comprised of a group of 135 women (26% Latina,
55% non-Hispanic White, 11% Black; 39% low-income) found to have elevated levels of
depressive symptoms. Median age was 31.81 years and those originally recruited were 25 weeks
gestational age (GA) or less, 18–45 years old, English speaking, and carrying a singleton.
Participants completed questionnaires during early pregnancy, prior to COVID-19, and during
COVID-19. The Edinburgh Postnatal Depression Scale (EPDS) and State Trait Anxiety
Inventory (STAI) short form were among the questionnaires completed by the participants.
Loneliness was measured in the COVID-19 assessment using an 8-item version of the UCLA
Loneliness Scale, and Income-to-Needs Ratio (INR) was calculated by dividing the total reported
household income by the poverty threshold corresponding to the number of persons living in the
household at the time of assessment. Stressors such as job loss, inability to work from home, and
exposure to COVID-19 for self and/or family were evaluated. Recruitment arose from current
participants in the Care Project, a randomized control trial of interpersonal psychotherapy for
distraught pregnant women. The authors continue the theme introduced by Gonzalez-Garcia et
al. (2021) and Moyer et al. (2020) by mentioning that exposure to uncontrollable stressors,
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including the COVID-19 pandemic intensifies maternal mental health struggles. This study arose
out of a need to evaluate the effect of the pandemic on mental health and to classify risk and
protective factors. The authors hypothesized that the following factors would contribute to a
greater increase in depression and anxiety symptoms pre-pandemic to during the pandemic:
1. Greater loneliness
2. Greater socio-economic risk
3. Greater COVID-19 specific adversity
Review of the data revealed a distinct break between adversity scores 2 and 3, therefore
participants were separated into the lower adversity group (score 0-2, n=94) and higher adversity
group (score 3+, n=41). Results revealed that depression symptoms were markedly higher during
COVID-19 and early pregnancy compared to pre-COVID-19. Similarly, anxiety symptoms were
higher during COVID-19 compared to pre-COVID-19 and early pregnancy. Greater loneliness
was found to be linked with increased depression symptoms during COVID-19, and greater
COVID-19 adversity found to be attributed to an increase in internalizing symptoms during
COVID-19. Additionally, greater loneliness was associated with both elevated depressive and
anxiety symptoms at all three timepoints, and income-to-needs ratio was discovered to be the
strongest predictor of symptoms during early pregnancy. Participants in the lower INR group
reported higher depression and anxiety symptoms during early pregnancy and during the
COVID-19 pandemic compared to pre-pandemic assessment. With the higher INR group,
symptoms of depression and anxiety were greater during COVID-19 compared to early
pregnancy. While the low INR group reported elevated anxiety and depression scores compared
to the higher INR group, the two groups did not differ significantly prior to or during the
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COVID-19 pandemic. Specifically regarding the COVID-19 adversity data, symptoms of
depression and anxiety were higher during the pandemic compared to pre-pandemic for the low
adversity group, but not during early pregnancy. For the high adversity group, depression
symptoms were higher compared to the low adversity group during the pandemic, but not prior.
Based on ACOG screening guidelines, the following percentages of women were found to be
above the cutoff of 10 on the EPDS:
35% of during pregnancy, 15.5% prior to the COVID-19 pandemic, 33.3% during the pandemic.
The authors longitudinal analysis suggests that the COVID-19 pandemic resulted in an increase
in internalizing symptoms among diverse pregnant and postpartum women with interpersonal
and contextual factors exacerbating the risk and impact of the pandemic on women’s mental
health.
Similar to Perzow et al. (2021), Boekhorst et al. (2021) conducted a longitudinal
prospective cohort study. Recruitment for the Boekhorst et al. (2021) study, also called the
Brabant Study, began in 2019 and continued into the pandemic. Eligible participants included
Dutch pregnant women over 18 years of age attending their first antenatal visit before 14 weeks
gestation. Participants completed online questionnaires during all three trimesters of pregnancy
and 8 to 10 weeks postpartum. Up until March 01, 2020, 401 women completed questionnaires
during pregnancy (trimester 1: N = 393; trimester 2: N = 350; trimester 3: N = 350), of whom
250 also completed postpartum assessments. From March 01, 2020, to May 14, 2020, 268
women filled out at least one questionnaire during pregnancy (trimester 1: N=265; trimester 2:
N=203; trimester 3: N=110), and 59 completed a postpartum assessment, providing the authors
with a total of 669 questionnaires to analyze. Unfortunately, the study period ended before all the
women had completed assessment in the third trimester of pregnancy or postpartum. However,
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during pregnancy 436 completed all questionnaires, 131 completed two questionnaires and 102
completed one questionnaire. Location was significant in that Brabant, the Netherlands, is
considered one of the European epicenters of the COVID-19 pandemic. Depression symptoms
were measured using the 10-item Edinburgh Postnatal Depression Scale (EPDS) with a score
>12 identifying women at risk for high levels of postpartum depression. The 10-item adapted
version of the Tilburg Pregnancy Distress Scale (TPDS-NA) was used to assess pregnancy
worries surrounding fetal health, childbirth, and delivery. A mixed model analysis was
conducted and results revealed that the primary effect of the pandemic was not an important
indicator of depressive symptoms throughout pregnancy for the EPDS model. However, results
revealed a slight increase in depressive symptoms from trimester 1 to trimester 3, but the effect
of time was not shown to be a significant factor. Seven percent of the pre-pandemic and 8.5% of
the pandemic group had a score higher than 12 on the EPDS at 8–10 weeks postpartum, which is
suggestive of high levels of postpartum depression symptoms. Of note though is that placement
in the pandemic group was not correlated with high levels of postpartum depression symptoms.
In contrast, the TPDS-NA model revealed that the pandemic did have a primary effect on
pregnancy-specific stress symptoms with the effect of time on stress during pregnancy being
significant and decreasing over time. For example, there was a significant difference in stress
scores between trimester 3 and trimester 1, but not between trimester 3 and trimester 2.
Interestingly, the authors did not observe an increase in depression symptoms during pregnancy
nor an increase in the occurrence of high levels of postpartum depression symptoms during the
pandemic.
Mei et al. (2021) conducted a cross-sectional study of pregnant women to analyze
depression, anxiety, and stress levels in a Novel Coronavirus-Pregnancy Cohort (NCP) and a
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Healthy Baby Cohort (HBC). NCP (531 participants) was developed during the COVID-19
pandemic and conducted in March and April 2020 while the HBC (2352 participants) was
established in 2012 and was conducted from 2017-2018. Both groups used the 7 item
Generalized Anxiety Disorder version 7 (GAD-7) for anxiety assessment and the 10 item
Perceived Stress Scale (PSS) for stress analysis. The 10 item Center for Epidemiologic Study
Depression Scale (CES-D) and the 9 item Patient Health Questionnaire version 9 (PHQ-9) were
used to evaluate depression in the HBC and NCP groups, respectively. Maternal pre-pregnancy
overweight and obesity rates were higher in NCP than in HBC, resulting in overweight and
obesity at 18.64% and 6.81%, respectively in the NCP group and 13.95% and 3.39% in the HBC
group. Significant differences in depression and stress were found between participants in the
two studies, but no significant difference was found for anxiety between the two groups.
Specifically, depression rates were much higher in participants from NCP than those from HBC,
especially moderate-to-severe depression (10.36% vs. 0.55%). Regarding stress, participants in
HBC reported a higher rate than NCP (69.39% vs. 60.45%). Similar trends in depression,
anxiety, and stress scores were observed between the two groups. However, there were no
significant differences in depression, anxiety, or stress rates noted among the three trimesters in
either group. Vaginal bleeding during pregnancy was discovered to be associated with higher
maternal depression, anxiety, and stress risks. Through this study, the authors discovered that
pregnant women with pre-pregnancy obesity and high educational levels showed lower risks for
depression, anxiety, and stress than those with normal weight and low educational levels. Results
also revealed that the COVID-19 pandemic was correlated with higher depression but lower
stress risks in pregnant women.
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Pariente et al. (2020) analyzed the incidence of increased risk for post-partum depression
in women delivering during the COVID-19 pandemic compared to the incidence of increased
risk for post-partum depression among women delivering before the COVID-19 pandemic via a
cross-sectional cohort study. Recruitment and data collection occurred during the COVID-19
strict isolation period (March 18 - April 29, 2020), with women who delivered between
November 2016 - April 2017 serving as the comparison group. Participants included 223 women
who delivered during the COVID-19 strict isolation period, and 123 women who delivered
before the COVID 19 pandemic. Both groups delivered at Soroka University Medical Center
(SUMC) and were approached by the research team on day two post-partum for invitation to
participate. In addition to completing the EPDS during hospitalization in the maternity unit,
participants completed questionnaires regarding socioeconomic status, obstetrical history, and
current pregnancy. Results revealed that women delivering during the COVID-19 pandemic
showed a lower risk of having a high (≥ 10) EPDS score than women delivering before the
COVID-19 pandemic (16.7% vs 31.3%). Similarly, women delivering during the COVID-19
pandemic showed lower risk of having a very high (≥ 13) EPDS score than women delivering
before the COVID-19 pandemic (6.8% vs 15.2%). Rates of positive suicidal ideations (accounted
for in question number 10 on the EPDS questionnaire) were comparable between the groups
(0.5% vs 0.9%). These results led the authors to the conclusion that delivering during the
COVID-19 pandemic was independently associated with lower risk for possible maternal
depression according to both EPDS score ≥ 10 and EPDS score ≥ 13.
Puertas-Gonzalez et al. (2021) examined the psychological health of pregnant women
during the COVID-19 pandemic through investigating psychopathological symptomatology and
stress. The psychopathological symptoms and stress of a group of women who were pregnant
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during the pandemic were compared with those of a group of women who were pregnant prior to
COVID-19, and the factors that could potentially influence the differences found between both
groups were calculated. Participants included 100 women in the Pre-Pandemic Group (PPG) and
100 women in the Pandemic Group (PG) with the PPG participants having been enrolled in the
Gestastress study prior to the current study. Pregnant women who were over the age of 18, in
their second or third trimester of pregnancy, and capable of reading and writing in Spanish were
eligible for inclusion, but those being actively treated with psychopharmaceuticals were
ineligible. Overall, the PG presented with more psychopathological symptoms than the PPG,
especially regarding depression and phobic anxiety. Interestingly, it was discovered that
insomnia combined with the recent loss of a loved one increased the scores on the depression
dimension of the Symptom Checklist-90-Revised (SCL-90-R), and that fear of contracting the
virus resulted in an 11% increase in the phobic anxiety scores of the SCL-90-R.
Authors concluded that insomnia, recent loss of a loved one, and the fear of being infected with
the COVID-19 virus were found to be predictive indicators of the participants
psychopathological symptomology. Particularly, the fear of being infected with the COVID-19
virus was found to increase phobic anxiety levels in the PG group. Results also revealed higher
levels of perceived stress among the PG, potentially due to uncertainty, high infection rate, high
mortality rate, and fear of contracting the disease.
Common themes that emerged through analyzing the data of the forementioned studies
are:
1. Pregnancy and post-partum unique period of vulnerability and heightened emotions
2. Changes in prenatal care
3. Anxiety of uncertainty
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4. Fear of infection
5. Social isolation
6. Lack of support
7. Mental health challenges in pregnancy associated with birth defects
8. Overflow of information on social media contributing to anxiety and subsequent behavior
Distribution of the themes contained in each article that emerged from the data analysis are
displayed in Table 1.
Table 1 – Emerging Themes
Article

Boekhorst
et al.
(2021)

GonazlezGarcia et
al. (2021)
Moyer et
al. (2020)
Mei et al.
(2021)
Overbeck
et al.
(2021)
Pariente
et al.
(2020)
Perzow et
al. (2021)
PuertasGonzalez
et al.
(2021)

Vulnerability

Care
Changes

✓

✓

✓

Support

Baby’s
Health

Uncertainty/
Fear of
Infection

Social
Isolation

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

Social
Media
Info.

Job

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓

✓
✓

✓

✓
✓

✓
✓

✓
✓
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Discussion
Extracted themes from analyzing the data provide valuable insight into the effects that the
COVID-19 pandemic has had on the mental health of pregnant women. Across each of the eight
articles analyzed, results revealed that being pregnant during the pandemic was shown to
produce increased levels of anxiety, stress, and depression. Contributing factors included social
isolation, fear of the unknown, concern for the baby, disruption in care, lack of control, and
drastic lifestyle changes. Alleviating factors included strong social support, delivery of healthy
baby, low risk of contamination with the virus, and lack of exposure to media. Detailed
discussions of each article analyzed are given in the remaining paragraphs of this section.
Gonzalez-Garcia et al. (2021) discovered that social support serves as a defense against
postpartum anxiety. Results obtained confirmed the authors hypothesized connection between
concern for the baby due to COVID-19 and symptoms of anxiety and depression. Further,
prevalence of postpartum PTSD amongst the participants was similar to that observed in the
control sample and therefore was not considered an influential factor. In contrast, however, the
authors observed a higher level of antenatal anxiety amongst the study participants compared to
the control sample, but this was not shown to have either a protective or harmful influence on the
occurrence of PTSD. Regarding the emotional regulation hypothesis, changes in the scores were
minimal and shown to be non-significant leading the authors to conclude that the participants had
no difficulty with emotional regulation. The authors instruct that this study should be considered
exploratory and results interpreted cautiously. This is primarily due to the sample size associated
with the Spearman’s correlations.
Moyer et al. (2020) analysis leads to the suggestion that factors independent of pregnancy
appear to be the force behind the changes in pregnancy – specific anxiety. This study builds upon
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previous research that established pregnancy related anxiety as distinct from general anxiety or
depression and is therefore manifested in more detrimental maternal or child outcomes. Further,
it demonstrates two important contributors to pregnancy-related anxiety: 1) real or anticipated
threat to pregnancy or its outcomes 2) low perceived control. Moyer et al. (2020) findings are
found to be consistent with the literature that women who experienced their pregnancies as
potentially threatened by the pandemic showed greater changes in pregnancy-related anxiety, and
that women who experienced a disruption in their anticipated pregnancy and delivery experience
showed greater changes in pregnancy-related anxiety. These findings contribute to a line of
research documenting the effects of disaster, trauma, and life stressors during pregnancy on
maternal mental health, confirming the detrimental impact of COVID-19 and its psychosocial
ramifications. Included in the detrimental impacts of COVID-19 are heightened interfamilial
tension and sociodemographic hardship on increasing pregnancy-related anxiety. The
retrospective format allowed the participants to serve as their own control sample rather than
comparison to another study and therefore makes this study unique.
Overbeck et al. (2021) proved to be a rather insightful study with the lone statistically
significant difference between the two groups being pregnancy history. Zero statistical
significance was observed regarding MDI scores between the two groups, but the ASS score was
observed to be slightly higher in the COVID-19 cohort. However, what is most revealing in this
study is the authors’ explanations for the recorded mild impact of the COVID-19 pandemic on
the mental health of pregnant women in Denmark. Reasons cited by Overbeck et al. (2021) for
the mild impact of the pandemic on the mental health of Danish pregnant women include the
lack of a curfew in Denmark, stores remaining open, freedom in moving about in society, and
healthcare facilities not being overwhelmed with patients. Additionally, in Denmark the COVID-
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19 virus might not have had a major impact on mental health due to the fact that the health threat
was quickly discovered to be low. Rather, any impact on mental health is seen to stem more from
the societal and economic consequences of the pandemic lockdown.
Perzow et al. (2021) longitudinal study of racially and ethnically diverse women during
the prenatal and postpartum periods exposed the fact that symptoms of depression and anxiety
were elevated following the onset of the COVID-19 pandemic compared to pre-pandemic
findings. Of particular interest is that an increase in symptoms was compounded in women
reporting more loneliness and COVID-19 specific adversity. Data revealed that depression
symptoms rose from before to during the COVID-19 pandemic and were as high as symptom
levels seen during early pregnancy. This suggests that the COVID-19 pandemic shifts symptom
trajectories, as evidenced by a resurgence of depressive symptoms equivalent to levels
experienced during early pregnancy and the increase of anxiety symptoms to a level higher than
previously experienced amongst the participants. Results also suggest that uncontrollable stress
and unpredictability surrounding the pandemic presented a risk for depression and anxiety
among pregnant and postpartum women regardless of INR.
Results from the Boekhorst et al. (2021) study led to the conclusion that in spite of the
fact that other studies have discovered an association between prenatal symptoms of anxiety and
postpartum depression symptoms, the presence of COVID-19-related worries and anxiety during
pregnancy could be unrelated to postpartum depression. In fact, Boekhorst et al. (2021) purport
that after childbirth has occurred COVID-19-related anxiety decreases, especially if the newborn
is healthy. However, study generalizations were limited by participant demographics, small
sample size, and design not allowing for assessment of change in symptoms of depression and
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stress from the prenatal to postnatal period, nor a comparison in this change between the
pandemic and pre-pandemic group.
In the Mei et al. (2021) study, the authors propose several reasons for the interesting
findings of the anxiety rate in NCP bearing no statistical difference compared to HBC, and the
stress rate for NCP being lower than HBC:
1. Participants in the study were not infected with coronavirus, and most families had no
infected members.
2. During the COVID-19 outbreak, participants had at least one companion, most of whom
was their husband, which may have led them to feeling more at ease.
3. During the pandemic, participants did not need to work, therefore reducing work-related
stress.
Results led Mei et al. (2021) to the conclusion that the pandemic as well as pre-pregnancy
weight status and educational level impacted the degree of depression experienced by the
pregnant population. Additionally, the authors suggest that the higher depression rate during
COVID-19 could be attributed to the sudden change in lifestyle following lock-down
policies.
In the Pariente et al. (2020) study, the authors propose the following as rationale for the
negative association between delivery during the strict isolation period of the COVID-19
pandemic and maternal depression observed in the study:
1. The circumstances of being quarantined with family provided the expectant mothers with
greater support. Quarantine also resulted in shorter hospital stays for the new mothers,
which the authors presume to be associated with a lower risk of post-partum depression.
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2. Lack of exposure to serious COVID-19 cases in the region where the study was
conducted.
3. Participants not having to confront day to day realities of society due to quarantine.
4. Previous reports that many disaster victims do not develop short or long-term
psychopathology.
5. Quarantine allowing for the increase of post-partum bonding and partnership satisfaction
serving as a buffer to post-partum symptoms of anxiety.
Additionally, the authors discovered a significant difference in the marital status between the two
populations (90.6% COVID-19 group vs 79.1% pre-COVID-19 group), which they determined
could be contributory to the lower prevalence of depression among women who delivered during
the COVID-19 pandemic.
Results from the Puertas-Gonzalez et al. (2021) study are consistent with similar studies
in showing that pandemics serve as a precursor to the psychopathological symptoms experienced
by pregnant women. The authors suggest that the drastic change in life instituted by the
quarantine was a major contributing factor to the increase in the participants stress levels along
with the media’s continual broadcast regarding the severity and lethality of the virus. Constant
media inundation was also attributed to the increase in the participants depression symptoms and
psychological dysphoria.
Conclusions
As evidenced by the emerging themes of the data analyzation and discussion above,
COVID-19 has had a profound and noticeable effect on the mental health of pregnant women. In
some instances, the anxiety and stress brought about by the pandemic have led pregnant women
to making changes in their health behaviors. Some of the changes include moving the birth of the
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baby from a hospital to the home setting, avoidance behavior, ceasing in-person visits, and
utilizing telehealth for prenatal care. What can be observed is that in places, such as Denmark,
where there were not strict mandates and lockdowns instituted and when the pregnant woman
had strong familial and partner support, the impacts of the pandemic on the pregnant woman’s
mental health were not as severe as in places where strict mandates and isolation were imposed.
Thus, it can be concluded that the true cause of the mental health impact on pregnant women
should be more accurately attributed to the societal, economic and media response to the
pandemic than to the virus itself.
Implications for Nursing
Nurses are at the forefront of responses to COVID-19 and are the largest group of
healthcare professionals (Choi et al., 2020). There are approximately 20 million nursing
professionals throughout the world with America representing four million of the total number.
Individuals who claim the title of Registered Nurse are responsible for their own physical and
mental wellbeing as well as the physical and mental health of the patients cared for and the other
health professionals on the same team. Trauma-informed care, a structure that takes into account
the consequences previous trauma can have on current decisions, attitudes and coping ability is
reported to be helpful in reducing retraumatization during health care appointments (Hall et al.,
2021). Emerging evidence suggests the SARS-CoV-2 virus is disproportionately affecting
pregnant women (Hall et al., 2021), specifically due to the stress of birth preparations during a
pandemic and concern over becoming infected. This stress can increase the pregnant
population’s risk for moderate or severe anxiety above and beyond sociodemographic, obstetric,
and other health factors. Therefore, training in the principles of trauma-informed care (TIC) is
recommended for nurses to enhance practice and patient care. Further support for nurses being
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trained in TIC is provided by Brooks et al. (2020) who inform that a mental health pandemic is
the consequence of the quarantine of the COVID-19 pandemic. Choi et al. (2020) advise that
pregnant women are a population of special concern regarding the consequential mental health
pandemic. TIC follows four key assumptions and six guiding principles and is best accomplished
through the assessment of and assistance with the pregnant patient’s psychosocial concerns
(SAMHSA, 2014). Clinicians expressing sensitivity through realizing and normalizing survivor
experiences of past trauma, recognizing survivors’ behaviors as coping mechanisms, responding
by creating a safer environment, and seeking to avoid retraumatization are the four key
assumptions of TIC. Safety, trustworthiness, collaboration, peer support, empowerment, and
cultural sensitivity are the six guiding principles. Using relationship-based care to foster
reciprocal social connections among patients, families, and staff is one of TIC’s main goals with
the intended outcome of creating a buffer to mitigate stress, promote resilience, and improve
health outcomes. Choi et al. (2020) recommend the implementation of TIC in perinatal care and
Hall et al. (2021) suggest that TIC can be practiced with all pregnant women similarly to the
application of universal precautions. Sperlich et al. (2017) proposed a framework for the
adoption of TIC in the maternity care setting and highlighted the need for further education about
TIC in this area. Screening is the starting point of the framework and is followed by the
implementation of referrals to interdisciplinary programs such as Minding the Baby,
Compassionate Minds, Seeking Safety, and Parents Under Pressure. The reward of nurses
receiving training in TIC is the increased ability to provide emotional support to patients and the
decrease in provider burnout (Hall et al., 2021). In order for this to be accomplished, nursing
leaders need to ensure that their staff receive the support and protection needed to provide TIC
(Choi et al., 2020). Additionally, nurses need to advocate for a comprehensive public health

COVID-19 MATERNITY CARE CHANGES

34

response to COVID-19 including the resultant mental health implications. Through preparing for
a potential second pandemic of mental distress related to COVID-19, the nursing profession can
improve resilience in our mental health organizations and communities.
Limitations
Through the integrative review process, certain limitations of the studies incorporated in
the data analysis were noted. Boekhorst et al. (2021), Pariente et al. (2020), and PuertasGonzalez et al. (2021) all mention time as a limitation of the respective studies. Specific time
limitations include the inability to assess for changes in depression and stress symptoms from
prenatal to postnatal period or between the pandemic and pre-pandemic groups, lack of detection
of post-event non-traumatic stressors, seasonality effects of the recruitment windows, and
psychological evaluation instruments only assessing psychological state of the last month.
Limited generalizability due to demographic and geographic discrepancies, small sample size,
social desirability bias, drop out rates, self-reporting of data weakening the objectivity and
reliability of results, and recall bias due to reliance on retrospective assessment of pregnancy –
related anxiety prior to COVID-19 pandemic are other study limitations. Methodological
limitations included recruitment through different means for the two groups and the utilizing of
single-item variables in the regression models. Another limitation of note is that the correlational
nature of the data prohibits the making of causal conclusions regarding the effect of the
pandemic on mental health.
Recommendations for Further Research
In consideration of the novelty of the COVID-19 pandemic, recommendations for future
research have arisen out of the integrative review process. First, future studies assessing the
mental health of pregnant women during later outbreaks of COVID-19 should be conducted and
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compared to results published during data collection of the initial outbreak of the COVID-19
pandemic. Additionally, future studies of longitudinal design that assess the effects of COVID19 on depression and stress symptoms of pregnant women as well as those that evaluate the
father’s psychological state should be conducted.

35

COVID-19 MATERNITY CARE CHANGES

36

References
Acker, K., Eagen-Torkko, M., Riley, L. E., & Saiman, L. (2021). Covid-19 infection, prevention,
and control considerations in the obstetric environment. Clinical Obstetrics &
Gynecology, 65(1), 134–147. https://doi.org/10.1097/grf.0000000000000666
American College of Obstetricians and Gynecologists (2022). Vaccinating pregnant and lactating
patients against COVID-19: practice advisory. https://www.acog.org/clinical/clinicalguidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-forobstetric-gynecologic-care
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The
proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450.
https://doi.org/10.1038/s41591-020-0820-9
Boekhorst, M. G. B. M., Muskens, L., Hulsbosch, L. P., Van Deun, K., Bergink, V., Pop, V. J.
M., & van den Heuvel, M. I. (2021). The COVID-19 outbreak increases maternal stress
during pregnancy, but not the risk for postpartum depression. Archives of Women’s
Mental Health, 24(6), 1037–1043. https://doi.org/10.1007/s00737-021-01104-9
Breslin, N., Baptiste, C., Gyamfi-Bannerman, C., Miller, R., Martinez, R., Bernstein, K., Ring,
L., Landau, R., Purisch, S., Friedman, A. M., Fuchs, K., Sutton, D., Andrikopoulou, M.,
Rupley, D., Sheen, J.-J., Aubey, J., Zork, N., Moroz, L., Mourad, M., … Goffman, D.
(2020). Coronavirus disease 2019 infection among asymptomatic and symptomatic
pregnant women: Two weeks of confirmed presentations to an affiliated pair of New
York City hospitals. American Journal of Obstetrics & Gynecology MFM, 2(2), 100118.
https://doi.org/10.1016/j.ajogmf.2020.100118

COVID-19 MATERNITY CARE CHANGES

37

Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin,
G. J. (2020). The psychological impact of quarantine and how to reduce it: Rapid review
of the evidence. The Lancet, 395(10227), 912–920. https://doi.org/10.1016/s01406736(20)30460-8
Cameron, E. E., Joyce, K. M., Delaquis, C. P., Reynolds, K., Protudjer, J. L. P., & Roos, L. E.
(2020). Maternal psychological distress & mental health service use during the COVID19 pandemic. Journal of Affective Disorders, 276, 765–774.
https://doi.org/10.1016/j.jad.2020.07.081
Centers for Disease Control and Prevention (2022, February 18). COVID-19 vaccines while
pregnant or breastfeeding, https://www.cdc.gov/coronavirus/2019ncov/vaccines/recommendations/pregnancy.html
Centers for Disease Control and Prevention. COVID-19 vaccines: interim clinical
considerations for use of COVID-19 vaccines currently authorized in the United States
2021,
https://www.cdc.gov/vaccines/ covid-19/info-by-product/clinical – considerations.html
Centers for Disease Control and Prevention (2021, May 07). Scientific Brief: SARS-CoV-2
Transmission,
https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/sars-cov-2
transmission.html
Centers for Disease Control and Prevention (2022). United states COVID-19 cases, deaths, and
laboratory testing (NAATs) by state, territory, and jurisdiction,
https://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days
Cheng, C. (2022). Time-series associations between public interest in COVID-19 variants and
national vaccination rate: A google trends analysis. Behavioral Sciences (2076328X), 12(7), 223–N.PAG. https://doi.org/10.3390/bs12070223

COVID-19 MATERNITY CARE CHANGES

38

Choi, K., Heilemann, M., Fauer, A., & Mead, M. (2020). A second pandemic: Mental health
spillover from the novel coronavirus (COVID-19). Journal of the American Psychiatric
Nurses Association, 26(4), 340–343. https://doi.org/10.1177/ 1078390320919803
Choi, K., Records, K., Low, L., Alhusen, J., Kenner, C., Bloch, J., … Logsdon, C. M. (2020).
Promotion of maternal-infant mental health and trauma-informed care during the
COVID-19 pandemic. Journal of Obstetric, Gynecologic, & Neonatal Nursing, 49(5),
409–415. https://doi.org/10.1016/j.jogn.2020. 07.004
Ciapponi, A., Bardach, A., Mazzoni, A., Alconada, T., Anderson, S. A., Argento, F. J., Ballivian,
J., Bok, K., Comandé, D., Erbelding, E., Goucher, E., Kampmann, B., Karron, R., Munoz,
F. M., Palermo, M. C., Parker, E. P. K., Rodriguez Cairoli, F., Santa María, V., Stergachis,
A. S., … Buekens, P. M. (2021). Safety of components and platforms of covid-19 vaccines
considered for use in pregnancy: A rapid review. Vaccine, 39(40), 5891–5908.
https://doi.org/10.1016/j.vaccine.2021.08.034
Cullen, S., Doherty, J., & Brosnan, M. (2021). Women’s views on the visiting restrictions during
COVID-19 in an Irish maternity hospital. British Journal of Midwifery, 29(4), 216–223.
https://doi.org/10.12968/bjom.2021.29.4.216
de Oliveira, K. F., de Oliveira, J. F., Wernet, M., Carvalho Paschoini, M., & Ruiz, M. T. (2021).
COVID‐19 and pregnancy: A scoping review on pregnancy characteristics and
outcomes. International Journal of Nursing Practice (John Wiley & Sons, Inc.), 27(5), 1–
15. https://doi-org.proxy.kennesaw.edu/10.1111/ijn.12956
Farewell, C. V., Jewell, J., Walls, J., & Leiferman, J. A. (2020). A mixed-methods pilot study of
perinatal risk and resilience during COVID-19. Journal of Primary Care & Community
Health, 11, 1–8. https://doi-org.proxy.kennesaw.edu/10.1177/2150132720944074

COVID-19 MATERNITY CARE CHANGES

39

Georgia Department of Public Health (2022). Georgia Overall COVID-19 Status,
https://dph.georgia.gov/covid-19-daily-status-report
Gonzalez-Garcia, V., Exertier, M., & Denis, A. (2021). Anxiety, post-traumatic stress
symptoms, and emotion regulation: A longitudinal study of pregnant women having
given birth during the covid-19 pandemic. European Journal of Trauma & Dissociation,
5(2), 100225. https://doi.org/10.1016/j.ejtd.2021.100225
Hall, S., White, A., Ballas, J., Saxton, S. N., Dempsey, A., & Saxer, K. (2021). Education in
trauma-informed care in maternity settings can promote mental health during the
COVID-19 pandemic. JOGNN: Journal of Obstetric, Gynecologic & Neonatal
Nursing, 50(3), 340–351. https://doi.org/10.1016/j.jogn.2020.12.005
Harrison, V., Moulds, M. L., & Jones, K. (2021). Perceived social support and prenatal
wellbeing; The mediating effects of loneliness and repetitive negative thinking on anxiety
and depression during the COVID-19 pandemic. Women and Birth : Journal of the
Australian College of Midwives. https://doi.org/10.1016/j.wombi.2020.12.014
Hocaoglu, M., Ayaz, R., Gunay, T., Akin, E., Turgut, A., & Karateke, A. (2020). Anxiety and
post-traumatic stress disorder symptoms in pregnant women during the COVID-19
pandemic’s delay phase. Psychiatria Danubina, 32(3-4), 521–526.
https://doi.org/10.24869/psyd.2020.521
Kachikis, A., Englund, J. A., Singleton, M., Covelli, I., Drake, A. L., & Eckert, L. O. (2021).
Short-term reactions among pregnant and lactating individuals in the first wave of the
COVID-19 vaccine rollout. JAMA Network Open, 4(8), e2121310.
https://doi.org/10.1001/jamanetworkopen.2021.21310
Karavadra, B., Stockl, A., Prosser-Snelling, E., Simpson, P., & Morris, E. (2020). Women’s
perceptions of COVID-19 and their healthcare experiences: a qualitative thematic analysis
of a national survey of pregnant women in the United Kingdom. BMC Pregnancy &
Childbirth, 20(1), N.PAG.

COVID-19 MATERNITY CARE CHANGES

40

Koyucu, R. G., & Karaca, P. P. (2021). The covid 19 outbreak: Maternal Mental Health and
associated factors. Midwifery, 99, 103013. https://doi.org/10.1016/j.midw.2021.103013
Lam, T. T.-Y., Jia, N., Zhang, Y.-W., Shum, M. H.-H., Jiang, J.-F., Zhu, H.-C., Tong, Y.-G., Shi,
Y.-X., Ni, X.-B., Liao, Y.-S., Li, W.-J., Jiang, B.-G., Wei, W., Yuan, T.-T., Zheng, K., Cui,
X.-M., Li, J., Pei, G.-Q., Qiang, X., … Cao, W.-C. (2020). Identifying sars-COV-2-related
coronaviruses in Malayan Pangolins. Nature, 583(7815), 282–285.
https://doi.org/10.1038/s41586-020-2169-0
Liu, D., Li, L., Wu, X., Zheng, D., Wang, J., Yang, L., & Zheng, C. (2020). Pregnancy and
perinatal outcomes of women with coronavirus disease (covid-19) pneumonia: A
preliminary analysis. American Journal of Roentgenology, 215(1), 127–132.
https://doi.org/10.2214/ajr.20.23072
Liu, J., Hung, P., Alberg, A. J., Hair, N. L., Whitaker, K. M., Simon, J., & Taylor, S. K. (2021).
Mental health among pregnant women with COVID-19-related stressors and worries in
the United States. Birth (Berkeley, Calif.), 48(4), 470–479.
https://doi.org/10.1111/birt.12554
Mei, H., Li, N., Li, J., Zhang, D., Cao, Z., Zhou, Y., Cao, J., & Zhou, A. (2021). Depression,
anxiety, and stress symptoms in pregnant women before and during the COVID-19
pandemic. Journal of Psychosomatic Research, 149, N.PAG.
https://doi.org/10.1016/j.jpsychores.2021.110586
Moyer, C. A., Compton, S. D., Kaselitz, E., & Muzik, M. (2020). Pregnancy-related anxiety
during COVID-19: A nationwide survey of 2740 pregnant women. Archives of Women's
Mental Health, 1-9.
Muhaidat, N., Fram, K., Thekrallah, F., Qatawneh, A., & Al-Btoush, A. (2020). pregnancy
during COVID-19 outbreak: The impact of lockdown in a middle-income country on
antenatal healthcare and wellbeing. International Journal of Women's Health, Volume 12,
1065–1073. https://doi.org/10.2147/ijwh.s280342

COVID-19 MATERNITY CARE CHANGES

41

Nsoesie, E.O., Rader B., Barnoon Y.L., Goodwin, L, Brownstein, J. (2020) Analysis of hospital
traffic and search engine data in Wuhan China indicates early disease activity in the Fall
of 2019. Harvard Library Office for Scholarly
Communication, http://nrs.harvard.edu/urn-3:HUL.InstRepos:42669767
Osborne, L. M., Kimmel, M. C., & Surkan, P. J. (2021). The crisis of perinatal mental health in
the age of COVID-19. Maternal & Child Health Journal, 25(3), 349–352.
https://doi.org/10.1007/s10995-020-03114-y
Overbeck, G., Rasmussen, I. S., Siersma, V., Andersen, J. H., Kragstrup, J., Wilson, P., Hauskov
Graungaard, A., & Ertmann, R. K. (2021). Depression and anxiety symptoms in pregnant
women in Denmark during COVID-19. Scandinavian Journal of Public Health, 49(7),
721–729. https://doi.org/10.1177/14034948211013271
Pariente, G., Wissotzky Broder, O., Sheiner, E., Lanxner Battat, T., Mazor, E., Yaniv Salem, S.,
Kosef, T., & Wainstock, T. (2020). Risk for probable post-partum depression among
women during the COVID-19 pandemic. Archives of Women’s Mental Health, 23(6),
767–773. https://doi-org.proxy.kennesaw.edu/10.1007/s00737-020-01075-3
Perzow, S. E. D., Hennessey, E.-M. P., Hoffman, M. C., Grote, N. K., Davis, E. P., & Hankin, B.
L. (2021). Mental health of pregnant and postpartum women in response to the COVID19 pandemic. Journal of Affective Disorders Reports, 4, 100123.
https://doi.org/10.1016/j.jadr.2021.100123
Prabhu, M., Murphy, E. A., Sukhu, A. C., Yee, J., Singh, S., Eng, D., Zhao, Z., Riley, L. E., &
Yang, Y. J. (2021). Antibody response to coronavirus disease 2019 (COVID-19)
messenger RNA vaccination in pregnant women and transplacental passage into cord
blood. Obstetrics & Gynecology, 138(2), 278–280.
https://doi.org/10.1097/aog.0000000000004438
Puertas-Gonzalez, J. A., Mariño-Narvaez, C., Peralta-Ramirez, M. I., & Romero-Gonzalez, B.
(2021). The psychological impact of the COVID-19 pandemic on pregnant

COVID-19 MATERNITY CARE CHANGES

42

women. Psychiatry Research, 301. https://doi.org/10.1016/j.psychres.2021.113978
Rahaman, S. T. (2020). A Review on Effect of Covid-19 in Pregnant Women: A Comprehensive
Analysis on Effect of COVID-19 and other viral outbreaks on Pregnant
Women. Pharmaceutical & Biomedical Research, 6, 1–25.
https://doiorg.proxy.kennesaw.edu/10.32598/pbr.6.covid19.832.1
Roberts, D. L., Rossman, J. S., & Jarić, I. (2021). Dating first cases of COVID-19. PLoS
Pathogens, 17(6), e1009620. https://doi.org/10.1371/journal.ppat.1009620
Roberts, D. L., & Solow, A. R. (2003). When did the dodo become
extinct? Nature, 426(6964), 245. https://doi.org/10.1038/426245a
Rottenstreich, A., Zarbiv, G., Oiknine-Djian, E., Zigron, R., Wolf, D. G., & Porat, S. (2021).
Efficient maternofetal transplacental transfer of anti- SARS-COV-2 spike antibodies after
antenatal SARS-COV-2 bnt162b2 mrna vaccination.
https://doi.org/10.1101/2021.03.11.21253352
Salehi, L., Rahimzadeh, M., Molaei, E., Zaheri, H., & Esmaelzadeh‐Saeieh, S. (2020). The
relationship among fear and anxiety of Covid‐19, pregnancy experience, and mental
health disorder in pregnant women: A structural equation model. Brain and Behavior,
10(11). https://doi.org/10.1002/brb3.1835

Substance Abuse and Mental Health Services Administration. (2014). SAMHSA’s concept of
trauma and guidance for a trauma-informed approach.
https://ncsacw.samhsa.gov/userfiles/files/ SAMHSA_Trauma.pdf
Sharifi-Heris, Z., Moghasemi, S., Ghamsary, M., Moodi, S., Ghprbani, Z., & Amiri-Farahani, L.
(2021). Perceived risk of COVID-19 acquisition and maternal mental distress. British
Journal of Midwifery, 29(3), 140–149.
https://doi-org.proxy.kennesaw.edu/10.12968/bjom.2021.29.3.140

COVID-19 MATERNITY CARE CHANGES

43

Shayganfard, M., Mahdavi, F., Haghighi, M., Sadeghi Bahmani, D., & Brand, S. (2020). Health
anxiety predicts postponing or cancelling routine medical health care appointments
among women in Perinatal Stage during the Covid-19 lockdown. International Journal
of Environmental Research and Public Health, 17(21).
https://doi.org/10.3390/ijerph17218272
Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L.,
Marquez, P. L., Olson, C. K., Liu, R., Chang, K. T., Ellington, S. R., Burkel, V. K.,
Smoots, A. N., Green, C. J., Licata, C., Zhang, B. C., Alimchandani, M., Mba-Jonas, A.,
Martin, S. W., … Meaney-Delman, D. M. (2021). Preliminary Findings of mRNA Covid19 Vaccine Safety in Pregnant Persons. The New England Journal of Medicine, 384(24),
2273.
Sperlich, M., Seng, J., Li, Y., Taylor, J., & Bradbury-Jones, C. (2017). Integrating traumainformed care into maternity care practice: Conceptual and practical issues. Journal of
Midwifery & Women’s Health, 62(6), 661–672. https://doi.org/10.1111/jmwh.12674
Wainstock, T., Yoles, I., Sergienko, R., & Sheiner, E. (2021). Prenatal maternal COVID-19
vaccination and pregnancy outcomes. Vaccine, 39(41), 6037.
https://doi.org/10.1016/j.vaccine.2021.09.012
Waltz, E. (2022). The algorithm that mapped omicron: With antigenic maps, vaccines can
evolve with COVID-19 variants. IEEE Spectrum, Spectrum, IEEE, IEEE Spectr, 59(4),
26–31. https://doi.org/10.1109/MSPEC.2022.9754490
World Health Organization (2022). WHO Coronavirus (COVID-19) Dashboard,
https://covid19.who.int/
World Health Organization (2022). Tracking SARS-CoV-2 Variants,
https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
Wrobel, A. G., Benton, D. J., Xu, P., Calder, L. J., Borg, A., Roustan, C., Martin, S. R.,
Rosenthal, P. B., Skehel, J. J., & Gamblin, S. J. (2021). Structure and binding properties
of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2. Nature
Communications, 12(1), 837. https://doi.org/10.1038/s41467-021-21006-9

COVID-19 MATERNITY CARE CHANGES

44

Xiao, K., Feng, Y., Zhang, X., Li, N., Guo, Y., Li, X., Shen, X., Zhang, Z., Shu, F., Huang, W.,
Chen, R.-A., Xiao, L., Shen, Y., Zhai, J., Zhou, N., Wu, Y.-J., Peng, S.-M.,
Huang, M., Xie, W.-J., … Zhang, Z. (2020). Isolation of SARS-CoV-2related coronavirus from Malayan pangolins. Nature, 583(7815), 286–289.
https://doi.org/10.1038/s41586-020-2313-x
Zhang, S., Qiao, S., Yu, J., Zeng, J., Shan, S., Tian, L., Lan, J., Zhang, L., & Wang, X. (2021).
Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARSCoV-2 evolution. Nature Communications, 12(1), 1607. https://doi.org/10.1038/s41467021-21767-3
Zhang, Y.-Z., & Holmes, E. C. (2020). A genomic perspective on the origin and emergence of
SARS-CoV-2. Cell, 181(2), 223–227. https://doi.org/10.1016/j.cell.2020.03.035

COVID-19 MATERNITY CARE CHANGES

45

Appendix A

Screening

Identification

PRISMA flow Diagram

Records identified from:
CINAHL Database (n = 698)
KSU Library (n = 7069)

Abstracts screened:
CINAHL (n=25)
KSU Library (n=52)
Articles screened:
CINAHL (n=19)
KSU Library (n=37)

Articles scrutinized for both pre
and post COVID-19 data
(n = 16)

Articles included in data analysis
(n = 8)

Study title or purpose not aligned
with integrative review or was not
in English:
CINAHL (673)
KSU Library (n= 7017)

Abstract or preliminary reading of
article revealed misalignment
between integrative review and
article study:
CINAHL (n = 39)
KSU Library (n = 78)

Examination of article revealed
lack of both pre & post COVID19 data (n=8)

COVID-19 MATERNITY CARE CHANGES

47

Appendix B
Author, Date

Aim

Study Design/
Methods

Major Findings

Limitations

Boekhorst, M. G. B. M.,
Muskens, L., Hulsbosch, L.
P., Van Deun, K., Bergink,
V., Pop, V. J.
M., & van den Heuvel, M. I.
(2021)

Comparing perinatal
symptoms of
depression & stress
before & during the
pandemic.

Longitudinal
prospective cohort
Brabant Study of 669
Dutch women
01/07/2019 –
05/14/2020

Pregnancy-specific stress
increased significantly during
the pandemic, but depression
during pregnancy and postpartum did not.

Gonzalez-Garcia, V.,
Exertier, M., & Denis, A.
(2021).

Identify & understand
factors that impact
concern regarding
COVID-19 for
perinatal women and
subsequent coping
strategies.

Observed difference in the
prevalence of anxiety but not
postpartum PTSD between
study population and control
sample.

Mei, H., Li, N., Li, J.,
Zhang, D., Cao, Z., Zhou,
Y., Cao, J., & Zhou, A.
(2021)

Evaluate depression,
anxiety, and stress
symptoms in pregnant
women before and
during COVID-19
pandemic with an

Longitudinal study of
90 participants
comparing women in
2nd or 3rd trimester
during lockdown in
France (04/06-05/11
2020) to control
sample of those who
gave birth outside
lockdown period.
Participants
completed surveys at
2 separate timepoints:
1 – during pregnancy
2 – 1 month
postpartum
Cross-sectional
analysis of pregnant
women’s depression,
anxiety, and stress
levels in the Novel
Coronavirus-

1. Limited generalizability due to:
i) Narrow sample population
ii) Higher level of education
among participants than general
Dutch female population
iii) Higher rate of
marriage/partnership among
participants than general Dutch
population
2. Study design not conducive to
assessing change in symptoms
from pre to postnatal nor from prepandemic to pandemic
3.Smaller pandemic group sample
size compared to pre-pandemic
group
1. Social desirability bias
2. Participants not recruited
from population with
postpartum PTSD
diagnosis
3. Drop-out rate between
T1 & T2
4. Time frame between T1
& T2 too short
5. Weakened objectivity &
reliability of results due
to self-reported data

Significant difference in
depression rates between the
HBC & NCP as well as the
COVID-19 pandemic being
correlated with higher

1.

Comparison capability
reduction due to NCP
data gathered during
perinatal periods versus
20–28-week gestation for
HBC data

Questionnaires
Utilized
Edinburgh (Postnatal)
Depression Scale (EPDS)
Tilburg Pregnancy Distress
Scale (TPDS-NA)

Spielberger Trait
Anxiety Inventory (STAI)*
Edinburgh Postnatal
Depression Scale (EPDS)*
Multidimensional Scale of
Perceived Social Support
(MSPSS)*
City Birth Trauma Scale
(CBTS)**
Interpersonal Emotional
Regulation Questionnaire
(IERQ)**
Posttraumatic Growth
Inventory (PGI)**

Center for Epidemiologic
Study Depression Scale
(CES-D)
Patient Health Questionnaire
version 9 (PHQ-9)
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analyzation of risk
factors.

Moyer, C. A., Compton, S.
D., Kaselitz, E., & Muzik,
M. (2020)

Exploration of the
impact of COVID-19
on pregnant women’s
anxiety & the
identification of
factors associated
with changes in the
level of anxiety.

Overbeck, G., Rasmussen, I.
S., Siersma, V., Andersen, J.
H., Kragstrup, J., Wilson, P.,
Hauskov
Graungaard, A., & Ertmann,
R. K. (2021)

Provide insight into
the mental well-being
of Danish pregnant
women during
COVID-19.

Pariente, G., Wissotzky
Broder, O., Sheiner, E.,
Lanxner Battat, T., Mazor,
E., Yaniv Salem, S.,
Kosef, T., & Wainstock, T.
(2020)

Assess the risk for
post-partum
depression among
women delivering
during the COVID-19
pandemic as
compared to the risk
among women
delivering before the
COVID-19 pandemic.
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Pregnancy Cohort
study (NCP) and the
Healthy Baby Cohort
study (HBC). NCP
conducted during
COVID-19 pandemic
and HBC prior to the
pandemic.
TA cross-sectional
anonymous online
survey conducted
04/03/2020 –
04/24/2020 reflecting
participants
perception of
pregnancy anxiety
pre-COVID & then
during COVID-19.
Cohort study
comparing women
recruited from Danish
general practice from
04/08/2020 –
05/06/2020 with
control group from
2016.
Cohort study of
women delivering
singletons at Soroka
University Medical
Center 03/18/2020 –
04/29/2020 compared
to women delivering
prior to COVID-19 at
same location.

depression but lower stress
risks in pregnant women.

2.

3.

COVID-19 pandemic deeply
affecting pregnant women’s
mental health with factors
independent of pregnancy
responsible for changes
regarding pregnancy specific
anxiety.

1.

Participants of the lockdown
cohort showed a modest
elevation in anxiety compared
to control group, but no
difference observed regarding
depression symptoms
between the 2 groups.

1.

Women delivering during the
COVID-19 pandemic showed
lower risk of scoring high or
very high on the EPDS
compared to pre-COVID-19.

1.

2.

2.
3.

2.

3.

4.

Utilization of different
scales in evaluating
depression between the
NCP & HBC studies
Significant differences in
certain participant
demographics

Generalized Anxiety
Disorder version 7 (GAD-7)
Perceived Stress Scale (PSS)

Reliance on participants
retrospective recall of
symptoms
Convenience sample bias

10-point visual analog scale
(VAS) x2
Pregnancy Related Anxiety
Scale (PRAS)

Convenience sampling of
the lockdown cohort
Small sample size of
lockdown cohort
Lack of follow-up and
reminders with lockdown
cohort

Major Depression Inventory
(MDI)
Anxiety Symptom Scale
(ASS).

Context of natural
disaster leading to
individuals who display
and experience
symptoms but do not
meet diagnostic criteria
Timeframe of study not
sufficient for allowing
depression to manifest
itself
Effect of seasonality due
to recruitment for the 2
groups occurring in
different seasons
EPDS not exclusively
reflecting risk for PPD

Edinburgh Postnatal
Depression Scale (EPDS)
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Perzow, S. E. D.,
Hennessey, E.-M. P.,
Hoffman, M. C., Grote, N.
K., Davis, E. P., & Hankin,
B.
L. (2021)

Examined change in
internalizing
symptoms from
before COVID-19 to
during COVID-19
longitudinally &
moderation by risk
factors.

Longitudinal selfreport questionnaire
completed
04/13/2020 –
05/22/2020

Both depression and anxiety
symptoms were higher during
COVID-19 than pre-COVID19 and reflected results
obtained during 1st trimester
of pregnancy.

1.

Longitudinal study
design prohibiting causal
conclusions

Puertas-Gonzalez, J. A.,
Mariño-Narvaez, C.,
Peralta-Ramirez, M. I., &
Romero-Gonzalez, B.
(2021)

Examine the
psychological effects
caused by the
COVID-19 pandemic
on pregnant women,
as well as the factors
influencing those
effects.

Cross-sectional study
of 200 pregnant
women – divided into
100 pandemic group
(PG) & 100 prepandemic group
(PPG)

PG displayed more
psychopathological symptoms
than the PPG, specifically
greater levels of depression,
phobic anxiety, and stress
with insomnia discovered to
be a factor in the increase of
depression & stress.

1.

Evaluation tools limited
to assessing
psychological state of the
past month
Psychological state of the
father not included
Variation in recruitment
of the 2 groups
Evaluation of PG
occurring during
COVID-19 masking
influence of lockdown
outside of pandemic

2.
3.
4.

KEY:

* Completed during prenatal period

** Completed during postnatal period

Edinburgh Postnatal
Depression Scale (EPDS)
State Trait Anxiety Inventory
(STAI)
UCLA Loneliness Scale
Income-to-Needs Ratio
(INR)
NIH Coronavirus Health
Impact Survey – Adult SelfReport Baseline Short Form
Symptom Checklist-90Revised (SCL-90-R)
Perceived Stress Scale (PSS)
Prenatal Distress
Questionnaire (PDQ)
Athens Insomnia Scale (AIS)
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